Next Article in Journal
Clinical Presentation of Immune-Related Endocrine Adverse Events during Immune Checkpoint Inhibitor Treatment
Next Article in Special Issue
Cancer Therapeutic Targeting of Hypoxia Induced Carbonic Anhydrase IX: From Bench to Bedside
Previous Article in Journal
New Therapy Options for Neuroendocrine Carcinoma of the Pancreas—The Emergent Substance GP-2250 and Gemcitabine Prove to Be Highly Effective without the Development of Secondary Resistances In Vitro and In Vivo
Previous Article in Special Issue
Vitamin D and Hypoxia: Points of Interplay in Cancer
 
 
Review

Article Versions Notes

Cancers 2022, 14(11), 2686; https://doi.org/10.3390/cancers14112686
Action Date Notes Link
article pdf uploaded. 29 May 2022 09:56 CEST Version of Record https://www.mdpi.com/2072-6694/14/11/2686/pdf-vor
article xml file uploaded 31 May 2022 08:17 CEST Original file -
article xml uploaded. 31 May 2022 08:17 CEST Update https://www.mdpi.com/2072-6694/14/11/2686/xml
article pdf uploaded. 31 May 2022 08:17 CEST Updated version of record https://www.mdpi.com/2072-6694/14/11/2686/pdf
article html file updated 31 May 2022 08:19 CEST Original file -
article html file updated 3 August 2022 02:28 CEST Update https://www.mdpi.com/2072-6694/14/11/2686/html
Back to TopTop